OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00222658

Anhui Jiangnan Chemical Industry Co Ltd

Commodity ChemicalsVerified

Anhui Jiangnan Chemical Industry Co Ltd maintains a debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 2.34, suggesting it has sufficient short-term assets to cover its liabilities, but not in excess. Free cash flow stands at 971.51 million CNY, which is a positive sign for operational flexibility and reinvestment capacity. Profitability metrics show a return on equity (ROE) of 7.92% and a return on assets (ROA) of 3.49%. These figures are in line with the industry's typical performance, but the company's operating income of 1.34 billion CNY and net income of 757.55 million CNY suggest a relatively stable earnings profile. Gross profit of 3.03 billion CNY indicates a healthy margin, though the company's cost structure and pricing power will be key to maintaining this level of profitability. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to localized economic or regulatory risks, particularly in the Chinese market where it operates. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the current or next fiscal year. Capital expenditures of -504.44 million CNY suggest a reduction in investment in new projects or facilities, which may indicate a focus on cost control or a shift in strategic priorities. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. However, the risk assessment notes that net cash is negative after subtracting total debt, which could limit the company's ability to fund operations or respond to unexpected financial pressures. No recent events or filings have been disclosed that would significantly alter the company's risk or operational outlook. Analyst estimates for the company are mixed, with a mean price target of 7.80 CNY and a mean recommendation of 1.50, indicating a slight bias toward a buy rating. However, the lack of variance in price targets (all estimates are 7.80 CNY) suggests a consensus among analysts, which may reflect limited upside or downside potential in the stock.

30-day price · 002226+0.37 (+6.8%)
Low$5.32High$6.63Close$5.82As of22 May, 00:00 UTC
Profile
CompanyAnhui Jiangnan Chemical Industry Co Ltd
Ticker002226.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Anhui Jiangnan Chemical Industry Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

Anhui Jiangnan Chemical Industry Co Ltd maintains a debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 2.34, suggesting it has sufficient short-term assets to cover its liabilities, but not in excess. Free cash flow stands at 971.51 million CNY, which is a positive sign for operational flexibility and reinvestment capacity. Profitability metrics show a return on equity (ROE) of 7.92% and a return on assets (ROA) of 3.49%. These figures are in line with the industry's typical performance, but the company's operating income of 1.34 billion CNY and net income of 757.55 million CNY suggest a relatively stable earnings profile. Gross profit of 3.03 billion CNY indicates a healthy margin, though the company's cost structure and pricing power will be key to maintaining this level of profitability. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to localized economic or regulatory risks, particularly in the Chinese market where it operates. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the current or next fiscal year. Capital expenditures of -504.44 million CNY suggest a reduction in investment in new projects or facilities, which may indicate a focus on cost control or a shift in strategic priorities. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. However, the risk assessment notes that net cash is negative after subtracting total debt, which could limit the company's ability to fund operations or respond to unexpected financial pressures. No recent events or filings have been disclosed that would significantly alter the company's risk or operational outlook. Analyst estimates for the company are mixed, with a mean price target of 7.80 CNY and a mean recommendation of 1.50, indicating a slight bias toward a buy rating. However, the lack of variance in price targets (all estimates are 7.80 CNY) suggests a consensus among analysts, which may reflect limited upside or downside potential in the stock.
Key takeaways
  • The company maintains a moderate debt load and a stable liquidity position.
  • Profitability is in line with industry norms, with a ROE of 7.92% and ROA of 3.49%.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Analysts project a stable price target of 7.80 CNY, with a slight buy bias.
  • The company is expected to maintain a stable revenue trajectory with no significant growth or contraction.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.98B
Gross profit$3.03B
Operating income$1.34B
Net income$757.5M
R&D
SG&A
D&A
SBC
Operating cash flow$1.19B
CapEx-$504.4M
Free cash flow$971.5M
Total assets$21.73B
Total liabilities$12.16B
Total equity$9.57B
Cash & equivalents
Long-term debt$7.18B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.57B
Net cash-$7.18B
Current ratio2.3
Debt/Equity0.8
ROA3.5%
ROE7.9%
Cash conversion1.6%
CapEx/Revenue-5.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002226Activity
Op margin13.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin30.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity75.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target7.80 CNY
Median price target7.80 CNY
High price target7.80 CNY
Low price target7.80 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.42 CNY
Last actual EPS0.29 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 00:34 UTCJob: d3973d2a